Choosing where LEQVIO® is administered
determines how it will be acquired

  • Patient coverage types

  • Acquisition

  • Alternate injection/infusion centers

In-office Administration

Acquire LEQVIO through buy-and-bill
and/or a specialty pharmacy

  • Receipt icon

    BUY-AND-BILL

    • Office orders LEQVIO from specialty distributor

    • Office submits a claim for
      reimbursement for the cost of LEQVIO
      and administration

    • Download the Buy-and-Bill 5 Step Guide for more information

    View distributors
  • Specialty pharmacy icon

    SPECIALTY PHARMACY*

    • Office submits a LEQVIO prescription to
      the specialty pharmacy

    • Specialty pharmacy sends product to
      the office

    • Once administered, office submits a
      claim for cost of administration, but not
      cost of the product

    *Not allowed for patients with
    traditional Medicare coverage.

    View specialty pharmacies
Out-of-office Administration

Refer patient to an
alternate site of care
for injection

  • Site of care icon

    ALTERNATE SITE OF CARE

    • Alternate site of care handles ordering LEQVIO, administration, and reimbursement for all services

    • Office does not order or bill for LEQVIO

    • Download the Alternate Site of Care Referral Guide for more information

Locate alternate site of care

LEQVIO Distributors

If you intend to buy-and-bill, LEQVIO can be ordered through our authorized distributors.

LEQVIO Distributors

Distributor
Contact Info
Website
  • AmerisourceBergen Besse
    Medical (physician distribution)
  • Phone: 1-800-543-2111
    Fax: 1-800-543-8695
  • https://www.besse.com
  • AmerisourceBergen Specialty
    Distribution (health systems and
    specialty pharmacy)
  • Phone: 1-800-746-6273
    Fax: 1-800-547-9413
  • https://www.asdhealthcare.com

Novartis does not recommend the use of any particular distributor.

Group Purchasing Organizations

If you intend to work with a group purchasing organization (GPO), you can order through the following companies.

Group Purchasing Organizations

Group Purchasing Organization
Contact Info
Website

*IPN Solutions, also known as Specialty Practice Network, includes International Rheumatology Network (IRN), International Gastroenterology Network (IGN), and International Cardiology Network (ICN).

Novartis does not recommend the use of any particular group purchasing organization.

Download Buy-and-Bill 5-Step Guide

Specialty Pharmacies

Novartis has made LEQVIO widely available through specialty pharmacies (SP), in the event white-bagging is required or preferred.

The following SPs have self-identified as supporting HCP-administered medical benefit products like LEQVIO. This means they currently support white-bagging for physicians and have familiarity and comfort with processing under both the medical and pharmacy benefits. This may be an option for private payers that offer Medicare Advantage and commercial health plans. Medicare Part B does not apply, as it is mandatory buy-and-bill.

This list of SPs is not comprehensive and other SPs may be available to you and your patients. Inclusion in this list is not an endorsement and Novartis cannot guarantee accuracy of this list or coverage of product. Novartis does not recommend or require the use of any particular pharmacy. Any SP in the LEQVIO distribution network that fits these criteria may be added to this list by contacting leqvio.spteam@novartis.com. This list is periodically updated.

Specialty Pharmacies

Specialty Pharmacy
Contact Info
Website
  • AllianceRx Walgreens Pharmacy
  • Phone: 1-888-282-5166
    Fax: 1-888-570-4700
  • alliancerxwp.com

Novartis does not recommend the use of any particular specialty pharmacy.

LEQVIO Returns

For HCPs or facilities with technical complaints and replacement requests related to:

  • Product administration or user error issues
  • Temperature stability issues
  • Damaged, dropped, or lost units

Contact the Customer Interaction Center at
1‑888‑NOW‑NOVA (669‑6682)

For HCPs or facilities choosing to return expired LEQVIO units

For wholesalers or distributors choosing to replace damaged or expired LEQVIO units

Contact Novartis Pharmaceuticals Corporation at 1‑800‑526‑0175 or email tradeoperations.phuseh@novartis.com

  • Alternate Site of Care

    The LEQVIO Locator tool allows you to enter your
    patient's ZIP Code and find sites in their local area.

    Visit LEQVIO Locator tool

    Are you an alternate site of care that would like to be added to the LEQVIO Locator tool? Download the guide and follow the steps to sign up.

    The list of alternate sites provided in the locator is not comprehensive, and other sites may be available to you and your patients. These lists are maintained by a third party, and inclusion in the locator is not an endorsement of any of the sites.

  • Map image

IMPORTANT SAFETY INFORMATION
AND INDICATION

Expand Collapse

IMPORTANT SAFETY INFORMATION

LEQVIO is contraindicated in patients with a prior serious hypersensitivity reaction to inclisiran or any of the excipients in LEQVIO. Serious hypersensitivity reactions have included angioedema. Adverse reactions in clinical trials (≥3% of patients treated with LEQVIO and more frequently than placebo) were injection site reaction, arthralgia, and bronchitis.

Please click here for LEQVIO full Prescribing Information.

INDICATION

LEQVIO (inclisiran) injection is indicated as an adjunct to diet and statin therapy for the treatment of adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH), to reduce low-density lipoprotein cholesterol (LDL-C).

Please click here for LEQVIO full Prescribing Information.